Endocannabinoid System as a New Therapeutic Avenue for the Treatment of Huntington’s Disease
Huntington’s disease (HD) is a progressive, neurodegenerative disorder manifested by chorea as well as a variety of psychiatric abnormalities. Up to this date, only symptomatic treatment exists. Therefore, there is an urgent need for further therapies. Several neuroanatomical circuits are involved i...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2022
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/81976 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Endocannabinoid System as a New Therapeutic Avenue for the Treatment of Huntington’s Disease
- The Endocannabinoid System as a Potential Therapeutic Target for Amyotrophic Lateral Sclerosis
- Introductory Chapter: Motor Neurons – New Insights
- Nrf2 as a Potential Therapeutic Target for Treatment of Huntington’s Disease
- Targeting Axonal Transport: A New Therapeutic Avenue for ALS
- ROCK Inhibition – A New Therapeutic Avenue in Kidney Protection
- Targeting Transcriptional Dysregulation in Huntington’s Disease: Description of Therapeutic Approaches